Overview:
Gumboro is a viral disease that occurs due to infectious bursal disease virus (IBDV). It is also known as infectious bursal disease (IBD) targeting mainly the immune system of chickens. The Gumboro disease is widely observed in ducks and turkeys who are not induced with immunosuppression. The disease is highly contagious and occurs in chickens older than 3 weeks of age. The symptoms of Gumboro disease include staining of feathers near vent with feces and many urates, anorexia dehydration in pectoral, abdominal muscles and thigh, ruffled feathers as well as impaired kidneys. There are no treatments developed for the disease, however, multivitamin supplements and access to water may help to cure the disease.
Drivers:
Increasing occurrence of Gumboro disease and growing need for its prevention to reduce the loss of business are the factors expected to propel growth of the global gumboro disease market. For instance, in 2013, Science Alert published a data that shows Nigeria witnessed economic loss of more than 3 billion Nigerian currency due to Gumboro disease during 2009, 2010 and 2011.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/783
Moreover, in 2000, as per the data released by Centre d’etudes et de Recherché, Belgium, gumboro disease caused 5 % of mortality in the U.S., while in Japan and Europe the rate is higher 25 to 30% in broilers and 50 to 60% in laying hens.
Growing R&D activities with novel vaccines in the pipeline to prevent Gumboro disease is also expected to drive growth of the Gumboro disease market. For instance, CEVA manufacturers produced the Transmune IBD vaccines, which is effective for Gumboro disease.
Market taxonomy:
The global gumboro disease market is divided into species type, by vaccines type and by geography
By species type:
- Broilers
- layers
By vaccines type:
- conventional vaccines
- vectored vaccines
- antibody/ antigen complex vaccines
By region:
- North America
- Europe
- Latin America
- Middle East
- Asia Pacific
- Africa
Regional analysis:
The Gumboro Disease Market is regionally divided into North America, Europe, Latin America, Middle East, Africa, and Asia Pacific.
North America is expected to witness robust growth in the Gumboro disease market owing to increasing cases of the gumboro disease and growing investment in R&D. For instance, in 2015, as per the National Chicken Council the U.S. has nearly 9 billion production of broiler chicken having the highest number of chicken consumers in the region compared to any other region.
Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/783
Key players:
Major players active in the Gumboro Disease Market are ROMVAC Company SA, Jiangyin Caina Technology co. limited, Salfarm Danmark A/s., Ceva, PTSanbe Farma, Cios Co., and Vetbiochem.
Reasons to Purchase this Report
• Current and future of global Gumboro Disease Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/783
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Gumboro Disease Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Gumboro Disease Industry Impact
Chapter 2 Global Gumboro Disease Competition by Types, Applications, and Top Regions and Countries
2.1 Global Gumboro Disease (Volume and Value) by Type
2.3 Global Gumboro Disease (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Gumboro Disease Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Gumboro Disease Market Analysis
Chapter 6 East Asia Gumboro Disease Market Analysis
Chapter 7 Europe Gumboro Disease Market Analysis
Chapter 8 South Asia Gumboro Disease Market Analysis
Chapter 9 Southeast Asia Gumboro Disease Market Analysis
Chapter 10 Middle East Gumboro Disease Market Analysis
Chapter 11 Africa Gumboro Disease Market Analysis
Chapter 12 Oceania Gumboro Disease Market Analysis
Chapter 13 South America Gumboro Disease Market Analysis
Chapter 14 Company Profiles and Key Figures in Gumboro Disease Business
Chapter 15 Global Gumboro Disease Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837